RECURSION PHARMACEUTICALS, INC.
RXRX
54 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Oct 7 10:08 PM | Blake BorgesonDirector | Sale | 50,000 | $4.84 | $242.0K | 6,108,287(D) | View → |
| Oct 6, 2026 | Oct 7 10:08 PM | Robert HershbergDirector | Sale | 25,000 | $5.00 | $125.0K | 162,156(D) | View → |
| Oct 6, 2026 | Oct 6 3:48 PM | Borgeson Blake | Proposed Sale | 50,000 | $4.84 | $242.0K | — | View → |
| Oct 6, 2026 | Oct 6 3:09 PM | HERSHBERG ROBERT | Proposed Sale | 25,000 | $5.00 | $125.0K | — | View → |
| Sep 8, 2026 | Sep 10 9:55 PM | Najat KhanDirector, CEO and President | Sale | 22,408 | $3.52 | $78.8K | 2,072,890(D) | View → |
| Sep 8, 2026 | Sep 8 6:28 PM | Najat Khan | Proposed Sale | 22,408 | $3.52 | $78.8K | — | View → |
| Sep 1, 2026 | Sep 2 10:01 PM | Blake BorgesonDirector | Sale | 30,000 | $3.34 | $100.2K | 6,158,287(D) | View → |
| Sep 1, 2026 | Sep 1 8:21 PM | Borgeson Blake | Proposed Sale | 30,000 | $3.34 | $100.2K | — | View → |
| Aug 21, 2026 | Aug 21 3:27 PM | Gibson Christopher | Proposed Sale | 77,290 | $3.39 | $262.0K | — | View → |
| Aug 20, 2026 | Aug 20 3:32 PM | Gibson Christopher | Proposed Sale | 75,000 | $3.40 | $255.0K | — | View → |
| Aug 19, 2026 | Aug 19 3:54 PM | Gibson Christopher | Proposed Sale | 100,000 | $3.28 | $327.5K | — | View → |
| Aug 18, 2026 | Aug 18 9:14 PM | Gibson Christopher | Proposed Sale | 26,806 | $3.00 | $80.4K | — | View → |
| Aug 13, 2026 | Aug 13 4:58 PM | Gibson Christopher | Proposed Sale | 100,000 | $3.31 | $331.0K | — | View → |
| Aug 12, 2026 | Aug 12 3:56 PM | Gibson Christopher | Proposed Sale | 50,000 | $3.37 | $168.5K | — | View → |
| Aug 10, 2026 | Aug 10 8:59 PM | Gibson Christopher | Proposed Sale | 100,000 | $3.27 | $326.8K | — | View → |
| Aug 7, 2026 | Aug 7 4:42 PM | Gibson Christopher | Proposed Sale | 100,000 | $3.25 | $325.4K | — | View → |
| Aug 4, 2026 | Aug 6 9:09 PM | Blake BorgesonDirector | Sale | 30,000 | $3.25 | $97.5K | 6,188,287(D) | View → |
| Aug 4, 2026 | Aug 4 5:37 PM | Borgeson Blake | Proposed Sale | 30,000 | $3.25 | $97.5K | — | View → |
| Aug 4, 2026 | Aug 4 2:35 PM | Gibson Christopher | Proposed Sale | 75,000 | $3.27 | $244.9K | — | View → |
| Jul 30, 2026 | Jul 30 8:10 PM | Gibson Christopher | Proposed Sale | 75,000 | $3.00 | $225.0K | — | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Oct 7 10:08 PM | Robert HershbergDirector | Option Exercise | 25,000 | $2.22 | 500,000(D) | View → |
| Jun 5, 2026 | Jun 5 9:03 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,263,334(D) | View → |
| May 22, 2026 | May 27 8:15 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,303,334(D) | View → |
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Conversion | 60,000 | — | 4,343,334(D) | View → |
| Apr 22, 2026 | Apr 24 8:23 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,403,334(D) | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,443,334(D) | View → |
| Mar 23, 2026 | Mar 25 8:36 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,483,334(D) | View → |
| Mar 9, 2026 | Mar 11 9:41 PM | Christopher GibsonDirector | Conversion | 20,000 | — | 4,523,334(D) | View → |
| Feb 19, 2026 | Feb 20 12:30 AM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,543,334(D) | View → |
| Feb 4, 2026 | Feb 6 10:53 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,583,334(D) | View → |
| Jan 20, 2026 | Jan 23 12:34 AM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,623,334(D) | View → |